LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1)

LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1)

Overview

[Lrp1](/genes/lrp1) (Low Density Lipoprotein Receptor Related Protein 1) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

{{#vardefine:wikiId|}}
{{#vardefine:pageId|2207}}

<div class="infobox infox-protein">
<div class="infobox-header">LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1)</div>
<div class="infobox-image">

LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1)

Overview

[Lrp1](/genes/lrp1) (Low Density Lipoprotein Receptor Related Protein 1) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

{{#vardefine:wikiId|}}
{{#vardefine:pageId|2207}}

<div class="infobox infox-protein">
<div class="infobox-header">LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1)</div>
<div class="infobox-image">

</div>
<table class="infobox-table">
<tr><th>Protein Name</th><td>LRP1</td></tr>
<tr><th>Gene Symbol</th><td>[LRP1](/genes/lrp1)</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/Q07954" target="_blank">Q07954</a></td></tr>
<tr><th>PDB Structures</th><td>5JVH, 6A2O, 7S5L</td></tr>
<tr><th>Molecular Weight</th><td>~600 kDa (precursor), ~85 kDa (mature chain)</td></tr>
<tr><th>Subcellular Localization</th><td>Cell surface membrane, endosomes, cytoplasm</td></tr>
<tr><th>Protein Family</th><td>LDL receptor family</td></tr>
<tr><th>Aliases</th><td>[LRP1](/proteins/lrp1), A2MR, CD91, APOER</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-4dd0d19b" style="color:#ce93d8" title="Score: 0.48">LRP1-Dependent Tau Uptake Disruption...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">614 edges</a></td>
</tr>
</table>
</div>

Introduction

[LRP1](/proteins/lrp1-protein) (Low-Density Lipoprotein Receptor-Related Protein 1) is a large endocytic receptor involved in the clearance of multiple ligands including [amyloid-beta](/proteins/amyloid-beta) (Aβ), apolipoprotein E (ApoE), and various signaling molecules. LRP1 plays a crucial role in maintaining brain homeostasis and its dysfunction is implicated in Alzheimer's disease (AD) and other neurodegenerative disorders.

Structure

LRP1 is one of the largest membrane receptors, characterized by:

• Extracellular α-chain (~400 kDa): Contains multiple ligand-binding repeats (4 cluster II repeats, 8 cluster I repeats) arranged in complement-type repeats
• Transmembrane β-chain (~85 kDa): Single-pass transmembrane domain
• Cytoplasmic tail: Contains two NPXY motifs and one dileucine motif for endocytosis and signaling

Normal Function

In the healthy nervous system, LRP1 functions as:

Role in Disease

Alzheimer's Disease

LRP1 is critical in AD pathogenesis through its role in Aβ metabolism:

Parkinson's Disease

In PD, LRP1:

• Mediates α-synuclein clearance and degradation
• Regulates dopaminergic neuron survival
• Influences mitochondrial function through lipid metabolism

Other Neurodegenerative Diseases

• Amyotrophic Lateral Sclerosis (ALS): LRP1 modulates motor neuron vulnerability
• Multiple Sclerosis: Involved in demyelination and repair
• Stroke: Mediates post-ischemic inflammation and recovery

Signaling Pathways

LRP1 activates diverse intracellular signaling cascades:

Key signaling molecules:

• ERK1/2: MAPK pathway activation
• Akt/PKB: Cell survival signaling
• RhoA: Cytoskeletal regulation
• CaMKII: Synaptic plasticity

Therapeutic Targeting

LRP1 modulators are being explored for neurodegenerative diseases:

| Strategy | Compound | Status | Notes |
|----------|----------|--------|-------|
| LRP1 agonists | Peptide fragments | Preclinical | Enhance Aβ clearance |
| sLRP1 | Recombinant sLRP1 | Research | Decoy for Aβ |
| Gene therapy | LRP1 overexpression | Research | Viral vector delivery |
| Signaling modulators | Small molecules | Research | Target downstream pathways |

Biomarker Potential

Soluble LRP1 (sLRP1) in CSF and plasma is being studied as:

• Diagnostic marker for AD
• Indicator of BBB integrity
• Prognostic marker for cognitive decline

Key Publications

Cross-Links

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [LRP1 Gene](/proteins/lrp1-protein)
• [APOE Gene](/proteins/apoe-protein)
• [Amyloid-Beta](/proteins/amyloid-beta)
• ["ApoE"](/apoe-—-apolipoprotein-e)
• ["Blood-Brain Barrier"](/mechanisms/blood-brain-barrier)

Overview

Lrp1 (Low Density Lipoprotein Receptor Related Protein 1) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Lrp1 (Low Density Lipoprotein Receptor Related Protein 1) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

• Allen Human Brain Atlas: [LRP1 (LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1) expression](https://human.brain-map.org/microarray/search/show?search_term=LRP1 (LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1))
• Allen Cell Type Atlas: [LRP1 (LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1) cell type expression](https://celltypes.brain-map.org/)
• BrainSpan: [LRP1 (LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1) developmental expression](https://brainspan.org/)

See Also

• [Amyloid Cascade Pathway](/mechanisms/amyloid-cascade-hypothesis)
• [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Synthetic Biology BBB Endothelial Cell Reprogramming](/hypothesis/h-84808267) — <span style="color:#ffd54f;font-weight:600">0.56</span> · Target: TFR1, LRP1, CAV1, ABCB1
• [Circadian-Synchronized LRP1 Pathway Activation](/hypothesis/h-7e0b5ade) — <span style="color:#ffd54f;font-weight:600">0.52</span> · Target: LRP1, MTNR1A, MTNR1B
• [Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides](/hypothesis/h-b948c32c) — <span style="color:#ffd54f;font-weight:600">0.49</span> · Target: APOE, LRP1, LDLR
• [LRP1-Dependent Tau Uptake Disruption](/hypothesis/h-4dd0d19b) — <span style="color:#ffd54f;font-weight:600">0.48</span> · Target: LRP1

Pathway Diagram

The following diagram shows the key molecular relationships involving LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) discovered through SciDEX knowledge graph analysis: